| Patient | Gender | Age | Clinical stage | AC [cm] | Chemotherapy | CEA | CA 19-9 | Type of surgery | Histology | Grade | L/V/P | cT | cN | ypT | ypN | TRG | Residual cancer cells Avg/Max % | Local relaps | Distant relaps |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Responders | 01 | M | 30 | IIIA | 12 | Xel | N | N | LAR | A | 1 | 0 | 1 | 1 | 1 | 0 | 2 | 1/5 | 0 | 0 |
02 | F | 62 | IIIA | 13 | Xel | N | N | LAR | A | 2 | 0 | x | 1 | 1 | 1 | 2 | 2,5/5 | 0 | 0 | |
03 | F | 67 | IIA | 3,5 | Xel | N | N | APR | A | 2 | 0 | 3 | 0 | 1 | 0 | 2 | 7,5/15 | 0 | 0 | |
04 | M | 43 | IIIA | 9 | Xel | N | N | uLAR | A | 1 | 0 | 2 | 1 | 0 | 0 | 1 | 0/0 | 0 | 0 | |
05 | M | 40 | IIIB | 5 | Xel | E | N | APR | A | 2 | 0 | 3 | 1 | 3 | 1 | 2 | 1/5 | 0 | 0 | |
06 | M | 73 | IIA | 6,5 | Xel | N | E | uLAR | A | 2 | 0 | 3 | 0 | 0 | 0 | 1 | 0/0 | 0 | 0 | |
07 | M | 68 | IIIC | 6 | Xel | E | E | APR | A | 2 | 0 | 3 | 2 | 0 | 0 | 1 | 0/0 | 0 | 0 | |
08 | M | 58 | IIIB | 13 | Xel | N | N | APR | A | 1 | 0 | 3 | 1 | 3 | 0 | 2 | 2,5/40 | 0 | Y | |
09 | M | 68 | IIA | 4,5 | 5FU | N | N | APR | A | 2 | 0 | 3 | 0 | 0 | 0 | 1 | 0/0 | 0 | 0 | |
10 | M | 43 | IIA | 4 | Xel | N | N | uLAR | MA | 2 | 0 | 3 | 0 | 0 | 0 | 1 | 0/0 | 0 | 0 | |
Non-responders | 11 | M | 63 | IIIB | 7 | Xel | E | N | uLAR | A | 2 | 0 | 3 | 1 | 2 | 0 | 4 | 15/50 | 0 | 0 |
12 | M | 59 | IIIB | 9 | Xel | E | N | LAR | A | 2 | 0 | 3 | 1 | 3 | 0 | 4 | 40/60 | 0 | 0 | |
13 | M | 45 | IIIC | 4 | Xel | N | N | APR | A | 2 | 1P | 3 | 2 | 3 | 1 | 3 | 7,5/50 | Y | Y | |
14 | F | 64 | IIIC | 11 | Xel | N | N | LAR | A | 2 | 0 | 3 | 2 | 2 | 0 | 4 | 50/70 | 0 | 0 | |
15 | F | 60 | IIIA | 9 | Xel | N | N | LAR | A | 1 | 0 | 2 | 1 | 1 | 0 | 4 | 70/80 | 0 | 0 | |
16 | F | 69 | IIIC | 8 | Xel | N | N | LAR | A | 1 | 0 | 3 | 2 | 3 | 1 | 4 | 25/70 | 0 | 0 | |
17 | M | 32 | IIIC | 10 | Xel | N | N | LAR | A | 2 | 0 | 2 | 2 | 3 | 0 | 4 | 55/75 | 0 | 0 | |
18 | M | 53 | IIIC | 4 | Xel | N | N | APR | A | 3 | 0 | 3 | 2 | 2 | 0 | 3 | 40/60 | 0 | 0 | |
19 | M | 63 | IV* | 7 | 5FU | E | N | APR | MA | 2 | 0 | 3 | 2 | 3 | 2 | 4 | 60/80 | 0 | Y | |
20 | F | 52 | IIA | 8 | Xel | N | N | LAR | A | 2 | 0 | 3 | 0 | 2 | 1 | 3 | 60/70 | 0 | 0 |